巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Sonoma Pharmaceuticals

    SNOA
    3.240
    0.000
    0.00%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Sonoma Pharmaceuticals - 延遲價格・最後更新於 10/08 12:00
    最高位
    --
    最低位
    --
    開市價
    --
    前收市價
    3.240
    成交量(千)
    --
    成交額(百萬)
    --
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    10.04
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    13.360 - 2.550
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Sonoma Pharmaceuticals
    證券代碼
    SNOA.US
    所屬板塊
    Drug Manufacturers - Specialty & Generic
    公司業務
    Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries.
    發行量
    3097674
    公司總部
    645 Molly Lane, Suite 150
    公司網址
    https://www.sonomapharma.com
    公司電郵
    ir@oculusis.com
    公司電話
    +1 800 759-9305
    暫無內容

    關於

    Sonoma Pharmaceuticals(SNOA.US)所屬的行業板塊為Drug Manufacturers - Specialty & Generic。
    Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries.
    詳細公司背景可參考: https://www.sonomapharma.com